Clinical Trials Logo

Hyposmia clinical trials

View clinical trials related to Hyposmia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06019000 Recruiting - Hyposmia Clinical Trials

Study of CYR-064 Versus Placebo in Patients.

Start date: September 26, 2023
Phase: Phase 2
Study type: Interventional

Randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR-064.

NCT ID: NCT05837637 Recruiting - Parkinson Disease Clinical Trials

The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease

Start date: May 5, 2023
Phase:
Study type: Observational

The goal of this observational study is to assess the value of the Vietnamese smell identification test (VSIT) in the diagnosis of Parkinson's disease, and compare it with the commonly used test in the world, Brisk smell identification test (BSIT) The main questions it aims to answer are: - The sensitivity, specificity, positive predictive value, and negative predictive value of the VSIT in the diagnosis of Parkinson's disease? - The sensitivity, specificity, positive predictive value, and negative predictive value of the BSIT in the diagnosis of Parkinson's disease? - Factors that associated with olfactory identification ability in PD patients? Process: - Participants will be assessed cognitive station using MMSE - Information on socio-demographic including age, gender, education, occupation, place of residence of both groups, and disease-related characteristics will be collected. - Participants with Parkinson disease will be then assessed with the following instruments: Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn & Yarh scale, and Beck Depression Inventory - The case and control groups will be assessed by the Vietnamese Smell Identification Test and Brisk Smell Identification Test

NCT ID: NCT05384561 Recruiting - COVID-19 Clinical Trials

Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

OTTODC19
Start date: May 2022
Phase: N/A
Study type: Interventional

Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors) with a placebo group. A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). The placebo group will train themselves with an odorless substance. Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.

NCT ID: NCT05364125 Recruiting - Anosmia Clinical Trials

Olfactory Training on Smell Dysfunction Patients in HK

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

- Causes of olfactory dysfunction can be classified into conductive and sensorineural causes. - Conductive causes are mainly due to structural nasal problem, which can be treated by nasal surgery - Sensorineural causes included post-infection, post-head injury, post Head and Neck irradiation and other central nervous system diseases. - Olfactory Training is well established treatment for sensorineural olfactory dysfunction in foreign countries. - Olfactory Training by neurological chemosensory stimulation using aromatic substances delivered via electronic portable aromatic rehabilitation (EPAR) diffuser was proved to be effective treatment in COVID-19 related olfactory dysfunction in recent Hong Kong study. - However, there is a lack of local study on the effect of Olfactory Training in other non-COVID-19 sensorineural causes of olfactory dysfunction in Hong Kong population.